Prelude Therapeutics
PRLD
#9186
Rank
NZ$0.12 B
Marketcap
$2.30
Share price
46.40%
Change (1 day)
-65.65%
Change (1 year)

Prelude Therapeutics (PRLD) - Cash on Hand

Cash on Hand as of September 2024 : NZ$0.27 Billion

According to Prelude Therapeutics's latest financial reports the company has NZ$0.27 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Prelude Therapeutics - Cash on Hand chart (from 2019 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31NZ$0.36 B15.93%
2022-12-31NZ$0.31 B-25.48%
2021-12-31NZ$0.42 B40.92%
2020-12-31NZ$0.30 B979.33%
2019-12-31NZ$28.03 M20.57%
2018-12-31NZ$23.24 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
NZ$0.48 B 77.29%๐Ÿ‡บ๐Ÿ‡ธ USA